相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability
Jian Zhang et al.
CANCER RESEARCH (2019)
Epigenetic drivers of tumourigenesis and cancer metastasis
Aniruddha Chatterjee et al.
SEMINARS IN CANCER BIOLOGY (2018)
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
Lena Gorgannezhad et al.
LAB ON A CHIP (2018)
Dramatic dysbalancing of the Wnt pathway in breast cancers
Alexey Koval et al.
SCIENTIFIC REPORTS (2018)
Cancer epigenetics: Moving forward
Angela Nebbioso et al.
PLOS GENETICS (2018)
Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists
Ping Yin et al.
CANCER SCIENCE (2018)
Incidence and Mortality and Epidemiology of Breast Cancer in the World
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma
Zhisen Shen et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Epigenetic control of gene expression: Potential implications for cancer treatment
F. Perri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males
Zhisen Shen et al.
DIAGNOSTIC PATHOLOGY (2016)
Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer
Orsolya Galamb et al.
EPIGENETICS (2016)
Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels
Christa Haldrup et al.
MOLECULAR ONCOLOGY (2016)
Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer
Ming Shan et al.
ONCOTARGET (2016)
DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis
Ming-Hong Tsai et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
Kun-Chun Chiang et al.
SCIENTIFIC REPORTS (2015)
β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
Jinhua Xu et al.
PLOS ONE (2015)
Shisa3 Is Associated with Prolonged Survival through Promoting β-Catenin Degradation in Lung Cancer
Chun-Chieh Chen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis
Muhammad Umer et al.
VIROLOGY JOURNAL (2014)
Epigenetic mechanisms of breast cancer: an update of the current knowledge
Seher Karsli-Ceppioglu et al.
EPIGENOMICS (2014)
Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer
Xie Zhang et al.
ONCOLOGY LETTERS (2014)
Microfluidics and cancer: are we there yet?
Zhuo Zhang et al.
BIOMEDICAL MICRODEVICES (2013)
Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells
Tingxiu Xiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
DACT1, an antagonist to Wnt/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
Xuedong Yin et al.
BREAST CANCER RESEARCH (2013)
Unexpected diversity in Shisa-like proteins suggests the importance of their roles as transmembrane adaptors
Jimin Pei et al.
CELLULAR SIGNALLING (2012)
Mammary gland development
Hector Macias et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2012)
Advantages and Disadvantages of Mammography Screening
Sylvia H. Heywang-Koebrunner et al.
BREAST CARE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma
Y. Guo et al.
NEOPLASMA (2011)
Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer
De-Yuan Fu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Wnt signaling in breast organogenesis
Kata Boras-Granic et al.
Organogenesis (2010)
Expression of Shisa2, a modulator of both Wnt and Fgf signaling, in the chick embryo
Thomas A. Hedge et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2008)
DNA methylation markers and early recurrence in stage I lung cancer
Malcolm V. Brock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mouse homologues of Shisa antagonistic to Wnt and Fgf signalings
Kenryo Furushima et al.
DEVELOPMENTAL BIOLOGY (2007)
Wnt signaling pathway in mammary gland development and carcinogenesis
Gulisa Turashvili et al.
PATHOBIOLOGY (2006)
Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF
A Yamamoto et al.
CELL (2005)
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
DR Rhodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
